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Exercise Alleviates Lipid-Induced Insulin Resistance in
Human Skeletal Muscle–Signaling Interaction at the
Level of TBC1 Domain Family Member 4
Christian Pehmøller,1 Nina Brandt,1 Jesper B. Birk,1 Louise D. Høeg,1 Kim A. Sjøberg,1
Laurie J. Goodyear,2 Bente Kiens,1 Erik A. Richter,1 and Jørgen F.P. Wojtaszewski1
Excess lipid availability causes insulin resistance. We examined
the effect of acute exercise on lipid-induced insulin resistance
and TBC1 domain family member 1/4 (TBCD1/4)-related signaling
in skeletal muscle. In eight healthy young male subjects, 1 h of
one-legged knee-extensor exercise was followed by 7 h of saline
or intralipid infusion. During the last 2 h, a hyperinsulinemic-
euglycemic clamp was performed. Femoral catheterization and
analysis of biopsy specimens enabled measurements of leg
substrate balance and muscle signaling. Each subject underwent
two experimental trials, differing only by saline or intralipid
infusion. Glucose infusion rate and leg glucose uptake was
decreased by intralipid. Insulin-stimulated glucose uptake was
higher in the prior exercised leg in the saline and the lipid trials.
In the lipid trial, prior exercise normalized insulin-stimulated
glucose uptake to the level observed in the resting control leg in
the saline trial. Insulin increased phosphorylation of TBC1D1/4.
Whereas prior exercise enhanced TBC1D4 phosphorylation on all
investigated sites compared with the rested leg, intralipid impaired
TBC1D4 S341 phosphorylation compared with the control trial.
Intralipid enhanced pyruvate dehydrogenase (PDH) phosphory-
lation and lactate release. Prior exercise led to higher PDH
phosphorylation and activation of glycogen synthase compared
with resting control. In conclusion, lipid-induced insulin resistance
in skeletal muscle was associated with impaired TBC1D4 S341
and elevated PDH phosphorylation. The prophylactic effect of
exercise on lipid-induced insulin resistance may involve aug-
mented TBC1D4 signaling and glycogen synthase activation.
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Studies in human and rodent models have revealeddeleterious effects of excess lipid availability onperipheral insulin sensitivity (1,2). Intracellularincreases in fatty acid metabolites, such as diacyl-
glycerol (DAG) and ceramide, may play critical roles in
mediating lipid-induced insulin resistance by inducing ser-
ine phosphorylation of insulin-receptor substrate 1 (IRS-1)
(3–6) and consequently inhibiting downstream signaling
to GLUT4 translocation. However, recent reports chal-
lenge such causality. These studies revealed unaltered
signal transduction at the level of IRS-1, IRS-1–associated
phosphatidylinositol-3-kinase (PI3K) activity, Akt, and TBC1
domain family member 4 (TBC1D4) phosphorylation
(phospho-Akt-substrate [PAS] an unspeciﬁc antibody rec-
ognizing phosphorylated Akt substrate motifs), after 2–7 h
of lipid infusion (7–11). When DAG and/or ceramide levels
were reported, no changes in skeletal muscle DAG or
ceramide levels were found after lipid infusion (7,11).
We recently showed that lactate release in human skel-
etal muscle is augmented along with reduced respiratory
exchange ratio (RER) values during lipid infusion (11). This
could indicate suppressed activity of the pyruvate de-
hydrogenase (PDH) complex, which in turn could lead to
a reduction in glucose uptake according to the Randle cycle
(12). Here, we wished to investigate whether this increase
in leg lactate release and reduced RER values were ac-
companied by altered regulation of PDH, measured by site-
speciﬁc phosphorylation.
Exercise increases peripheral insulin sensitivity (13–15).
After an acute bout of exercise, the ability for insulin to
stimulate glucose uptake in skeletal muscle is increased
several hours into recovery (14,16). This effect can be
ascribed to adaptations in the exercised muscle rather
than changes in systemic factors (13,17,18) and is ob-
served in both healthy and insulin-resistant states (e.g.,
obesity) (19) and type 2 diabetes (20). A recent study has
shown that a single bout of exercise can prevent sub-
sequent lipid-induced impairments in whole-body glucose
tolerance assessed by an intravenous glucose tolerance
test (IVGTT) (2). It was hypothesized that repartitioning
fatty acids toward intramuscular triacylglycerol (IMTG)
synthesis and storage rather than DAG or ceramide might
be a primary mediator of the beneﬁcial effects of exercise
on lipid-induced impairments in glucose tolerance (2). En-
hanced insulin sensitivity after a bout of exercise is asso-
ciated with increased GLUT4 recruitment to the plasma
membrane (21) and not with altered protein synthesis (e.g.,
GLUT4 protein) (22), but has not been associated with
altered signal transduction through the insulin receptor,
IRS-1, PI3K, or Akt (13,22,23). Recently, the hypothesis
was put forward (24) that the guanosine triphosphatase
(GTPase) activating proteins TBC1 domain family member
1 (TBC1D1) and 4 (TBC1D4) might serve as points of
convergence for insulin dependent and independent sig-
naling pathways to GLUT4 translocation. In agreement
with this hypothesis, PAS phosphorylation of TBC1D4 is
elevated along with insulin-stimulated glucose uptake for
up to 27 h after exercise in skeletal muscle of rats (25), and
we recently showed that phosphorylation of TBC1D4 on
speciﬁc residues was elevated 4 h after a single bout of
exercise in human skeletal muscle (26).
TBC1D4/D1 are multikinase substrates proposed to be
involved in contraction- and insulin-stimulated glucose
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uptake in mice (27,28), and exercise and insulin both
substantially increase TBC1D4/D1 phosphorylation in hu-
man skeletal muscle (29,30). TBC1D4/D1 contain several
phosphorylation sites distinctly phosphorylated by various
kinases, including Akt and 59AMP-activated protein kinase
(AMPK) (28,31–33). Phosphorylation of TBC1D4/D1 and
subsequent 14-3-3 binding is proposed to lead to inactivation
of the GTPase-activating proteins, decreasing their inhib-
itory function on the GLUT4 translocation process and thus,
potentially, increasing the GLUT4 capacity of the surface
membrane.
In the current study we tested the hypothesis that prior
exercise prevents subsequent lipid-induced insulin re-
sistance in human skeletal muscle through regulation of
the signaling molecules TBC1D4/TBC1D1.
RESEARCH DESIGN AND METHODS
Subjects. Eight healthy, moderately ﬁt men (Table 1) were included in the
study and gave their written informed consent. The study was approved by the
local ethics committee in the municipality of Copenhagen (KF 01 26 1127) and
performed in accordance with the Helsinki Declaration II.
Experimental design. All subjects underwent two experimental trials only
differing by infusion of intralipid and heparin or saline for 7 hours in a ran-
domized order. The trials were separated by at least 2 weeks. After 8 days of
a standardized diet (2.5 MJ; 60E% carbohydrate [CHO], 25E% fat, and 15E%
protein) that was provided in weighed portions to the subjects, the subject
arrived at the laboratory in the morning after having consumed a meal cor-
responding to 20% of daily energy intake (60E% CHO, 25E% fat, and 15E%
protein) 3 h earlier. The meal was added to avoid too high plasma fatty acid
concentrations in the few hours after exercise in the saline trial as a conse-
quence of a long fast. Previous studies have shown that when a pre-exercise
meal of 3 MJ is consumed, plasma glucose and insulin concentrations returned
to baseline values between 4 and 6 h after ingestion (34). Because the clamp
was initiated 8 h after the meal in the current study, we assume that the meal
would have no or at least a very minor impact on the metabolic responses.
Nevertheless, the protocol was identical for both of the following trials.
Upon arrival, the subjects performed 60 min of dynamic one-legged knee
extensor exercise at 80% peak workload of the knee extensors. During the
60 min of exercise two 5-min intervals at 100% peak workload were performed
(at the 20–25 and 40–45 min time points) to ensure activation of the majority of
the vastus lateralis muscle ﬁbers. At 20 min after termination of exercise, a 7-h
infusion of intralipid (20% soybean oil emulsion, Fresenius Kabi, Uppsala,
Sweden; 1.15 mL $ kg21$ h21) + heparin (0.2 units $ kg21$ min21) or saline
was initiated through a catheter inserted in an antecubital vein. Teﬂon cath-
eters were inserted into the femoral artery and both femoral veins and
a thermistor (EDSLAB T.D. Model 94-030-2.F, Baxter Healthcare Corporation,
CA) was inserted through the femoral vein catheter for blood ﬂow de-
termination. After 3 h of infusion of intralipid or saline, a bolus injection of
[6,6-2H] glucose was administered (3.203 mg $ kg21) within 1 min, followed by
a constant infusion (0.055 mg $ kg21$ min21) for the remaining experimental
period (4 h). After 5 h of intralipid or saline infusion, subjects underwent
a 120-min hyperinsulinemic-euglycemic clamp (1.42 mU $ kg21$ min21 insulin)
initiated with a bolus injection of insulin (9.0 mU $ kg21; Actrapid, Novo
Nordisk, Denmark). Femoral venous blood ﬂow was determined, and blood
was collected simultaneously from the femoral arteries and veins at260, 0, 15,
30, 45, 60, 80 100, and 120 min of the clamp. Expired air was collected in
Douglas bags before the clamp and at the end of the clamp. The subjects did
not consume any food throughout the experimental day.
Muscle biopsies. Biopsy specimens were obtained from both vastus lateralis
muscles 30 min before the clamp and at 30 and 120 min into the clamp. Muscle
samples were snap frozen in liquid nitrogen and stored at 280°C for later
processing. Biopsy specimens from both legs were obtained within ,2 min.
Insulin sensitivity. Insulin sensitivity at whole-body level was expressed as
the average glucose infusion rate during the last 40 min of the clamp normalized
to the steady-state plasma insulin concentration in the same period. Glucose
uptake across the thigh was calculated as the arterial – venous glucose dif-
ference multiplied by blood ﬂow (Fick’s Principle), and insulin-stimulated
glucose uptake across the leg was expressed as a mean of the last 40 min of
the clamp.
Methods for blood chemistry, RER, body composition, stable isotopes,
muscle tissue processing, glycogen, IMTG content, SDS PAGE and Western
blotting, antibodies, 14-3-3 overlay and glycogen synthase (GS) activity, and
calculation of hepatic glucose production are all presented in the Supple-
mentary Data.
Statistics. Data are expressed as means 6 SEM. Statistical analyses were
performed in SPSS 17.0 software (SPSS, Chicago, IL) and Sigma Plot 11.0
software (Systat Software Inc, Erkrath, Germany) using two- or three-way
ANOVA with repeated measures (RM). Three-way ANOVA RM was used for
comparison of exercise, insulin, and intralipid and two-way ANOVA RM for
comparison of insulin and intralipid or exercise and insulin. The Tukey post
hoc test was performed when ANOVA revealed signiﬁcant interaction. Finally,
paired Student t test was used for data shown in Fig. 1A. Correlation analyses
were performed in Sigma Plot 11.0 using Pearson product moment correlation.
Correlation of TBC1D4 phosphorylation with leg glucose uptake was calcu-
lated during insulin stimulation and included values from all four interventions
(saline/lipid and rest/exercise, n = 28).
RESULTS
Subject characteristics. Subject characteristics are pre-
sented in Table 1.
Insulin sensitivity. Preclamp plasma insulin levels were
not different between trials, and insulin infusion resulted
in arterial insulin levels ;100 mU $ mL21 in both trials
(Table 2).
Insulin-stimulated whole-body glucose infusion rate (GIR)
to maintain arterial blood glucose concentration at 5.26 0.1
mmol $ L21 (Table 2) leveled at 42.9 6 0.9 mmol $ min21$
kg21 body mass (BM) during the last 40 min of the clamp in
the saline trial. GIR/insulin was ;32% (P , 0.001) lower in
the intralipid trial compared with the saline trial (Fig. 1A).
Insulin-stimulated leg glucose uptake increased during
the clamp regardless of the intervention (P, 0.001; Fig. 1C
and D), but was ;30% (P , 0.01) lower in the rested and
previously exercised leg in the intralipid trial compared
with the saline trial (Fig. 1B). Insulin-stimulated leg glu-
cose uptake was higher in the previously exercised leg
compared with the rested leg in both trials (P , 0.05).
Hepatic glucose production (HGP). HGP was signiﬁ-
cantly suppressed during the last 40 min of the clamp in
both trials (P , 0.001). Although HGP was fully suppressed
in the saline trial, there was still a small but borderline
signiﬁcantly higher HGP in the lipid trial compared with the
saline trial (P = 0.051; power = 0.444; Table 2).
RER. RER was 0.79 6 0.02 preclamp in the saline trial and
increased to 0.85 6 0.02 (P , 0.01) at the end of the clamp
(Table 2). Insulin did not affect RER in the intralipid trial.
Thus, RER was signiﬁcantly lower at the end of the clamp
in the intralipid trial compared with the saline trial (P ,
0.01; Table 2).
Arterial plasma long-chain fatty acids (LCFAs). Ar-
terial plasma LCFA levels were approximately ﬁvefold
higher in the intralipid trial compared with the saline trial
(P , 0.001). Insulin suppressed plasma LCFA levels in
both trials by approximately the same absolute magnitude.
TABLE 1
Subject characteristics
Age (years) 28 6 2
Height (m) 1.80 6 0.02
Body mass (kg) 72.7 6 2.7
BMI (kg $ m22) 22.3 6 0.5
Body fat (%) 12.3 6 0.8
Lean body mass (kg) 63.8 6 2.5
Lean leg mass (kg) 8.6 6 0.4
VO2 peak
L $ min21 3.9 6 0.2
mL $ kg body mass21$ min21 54.1 6 1.4
mL $ kg lean body mass21$ min21 61.8 6 1.7
Data are expressed as means 6 SEM (n = 8).
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Thus, plasma LCFA levels were almost completely sup-
pressed in the saline trial, whereas in the intralipid trial,
plasma LCFA levels remained markedly elevated (1,894 6
300 mmol $ L21) above levels observed in the saline trial
(27.7 6 7.50 mmol $ L21; P , 0.001; Table 2).
Blood ﬂow and plasma parameters. Venous blood ﬂow
increased during the clamp (P , 0.05) in both trials and
tended (;17%, P = 0.058) toward being higher in the pre-
viously exercised leg compared with the rested leg (Table 2).
Leg blood ﬂow was not affected by intralipid infusion.
Arterial plasma concentrations of epinephrine and nor-
epinephrine were not affected by insulin, previous exer-
cise, or intralipid infusion (Table 2). Leg lactate release
was higher in the intralipid compared with the saline trial,
irrespective of the clamp (P , 0.01), but was not different
between the rested and exercised leg. Leg lactate release
did not change in response to insulin infusion (Table 2).
The increased lactate release in the intralipid trial did not
result in detectable increases in arterial lactate concen-
trations (Table 2).
Muscle glycogen and IMTG content. Muscle glycogen
content was lower in the previously exercised leg compared
with the rested leg before the clamp (P , 0.05; Table 2).
Muscle glycogen content increased marginally during the
clamp only in the previously exercised leg (P , 0.05), and
thus, the levels reached at the end of the clamp were still
lower compared with the rested leg (P , 0.05; Table 2).
Intralipid infusion did not affect IMTG levels in the vastus
lateralis muscle, and IMTG levels were not different be-
tween the rested and previously exercised leg before or at
the end of the clamp (Table 2).
Insulin signaling in skeletal muscle. Akt regulation was
evaluated by phosphorylation on two regulatory sites, S473
and T308. Insulin markedly increased S473 and T308
phosphorylation in all situations, but there was no effect of
prior exercise or intralipid infusion on either site (Fig. 2A
and C). In addition, Akt protein expression was not af-
fected by any of the interventions (Fig. 2D).
Insulin increased TBC1D1 phosphorylation at T596 in all
situations (P , 0.01), whereas S237 phosphorylation was
not affected (Fig. 3A and B). Neither prior exercise nor
intralipid affected basal and insulin-induced phosphoryla-
tion of these two sites. TBC1D1 protein expression was
not affected by the interventions (Fig. 3C).
Insulin increased phosphorylation of all TBC1D4 phos-
phorylation sites investigated in all situations (all P ,
0.001; Fig. 4B–G). In both the saline and intralipid trials,
the basal and insulin-induced phosphorylation at all sites
was signiﬁcantly higher in the previously exercised muscle
compared with the rested muscle. Lipid infusion signiﬁ-
cantly impaired phosphorylation of S341 by ;20% com-
pared with the saline trial (P , 0.05; Fig. 4C) under both
basal and during insulin-stimulated conditions. TBC1D4
S588 phosphorylation showed a similar pattern, but this
FIG. 1. A: Glucose infusion rate/arterial insulin concentration the last 40 min of the clamp. B: Insulin-stimulated leg glucose uptake during the last
40 min of the clamp (LLM, lean leg mass). Insulin-stimulated leg glucose uptake in the rested and previously exercised (Ex’d) leg during the 120
min of the clamp in the saline trial (C) and intralipid trial (D). Data are expressed as means 6 SEM (n = 8). #P < 0.05, ##P < 0.01 vs. saline trial;
††P < 0.01 vs. rested leg; *P < 0.05, **P < 0.01, ***P < 0.001 vs. basal (0 min) in respective trial.
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did not reach statistical signiﬁcance (Fig. 4D). Although
prior exercise increased phosphorylation at all sites, the
impairing effect of intralipid on TBC1D4 S341 phosphory-
lation was not fully rescued to the level seen in the saline
trial. At present we are not able to evaluate TBC1D4 GAP
activity in skeletal muscle biopsy specimens. We tested
whether the lower TBC1D4 S341 phosphorylation had any
consequence for the ability of TBC1D4 to bind to 14-3-3
proteins. Although 14-3-3 binding to TBC1D4 increased
during the clamp, no differences were observed between
the saline and intralipid trial or between the rested and
exercised leg (Fig. 4A). Nevertheless, correlation analyses
reveal a relatively weak, but statistically signiﬁcant, posi-
tive correlation between TBC1D4 S341 phosphorylation
and leg glucose uptake during insulin stimulation (R2 =
0.140, P , 0.005; n = 28 data not shown). TBC1D4 protein
expression was not affected by the interventions (Fig. 4H).
AMPK is a proposed upstream kinase for TBC1D1 and
TBC1D4, and AMPK function was evaluated by measuring
phosphorylation of T172 in the activating loop of the a2
subunit. AMPK phosphorylation was not affected by either
of the interventions (prior exercise, intralipid or insulin;
Fig. 2E).
Regulation of PDH. Regulation of PDH was evaluated by
phospho-speciﬁc antibodies toward two regulatory
(deactivating) phosphorylation sites of PDH (site 1 and 2).
Phosphorylation of PDH on site 1 was not affected by
any of the interventions (Fig. 5A). However, phosphor-
ylation of PDH site 2 was elevated in the previously ex-
ercised muscle compared with the rested muscle in all
situations (P , 0.05) and showed a trend (P = 0.08;
power = 0.403) toward higher phosphorylation in the
lipid trial compared with the saline trial (Fig. 5B). Pro-
tein expression of PDH was not affected by any of the
interventions (Fig. 5C).
GS activity. Insulin increased muscle GS activity (%
I-form and % fractional velocity [FV]) in all situations (P ,
0.001), and lipid infusion did not affect this increase
(Fig. 6A and B). Basal and insulin-stimulated GS activity (%
I-form and % FV) were higher in the previously exercised
muscle compared with the rested muscle (P , 0.001; Fig.
6A and B).
DISCUSSION
Acute intralipid infusion dramatically impaired whole-
body and leg insulin sensitivity. The latter effect was partly
prevented by prior exercise. Although we observed sub-
stantial lipid-induced reduction in skeletal muscle insulin
sensitivity (Fig. 1B), phosphorylation of Akt by insulin was
not affected (Fig. 2A and B). This conﬁrms our recent re-
port where insulin-stimulated IRS-1–associated PI3K activity
and Akt phosphorylation were also not impaired by 7 h of
intralipid infusion despite pronounced insulin resistance (11).
The unaltered proximal insulin signaling was also supported
by the unaltered insulin-induced activation of GS. Hence, our
data add to the accumulating body of evidence (7–9,11)
challenging the view (3–6) linking acute lipid-induced insulin
resistance to defects in proximal insulin signaling.
We recently reported that insulin-induced TBC1D4
phosphorylation detected with the PAS antibody was in-
tact after lipid infusion in human skeletal muscle (11).
Also, a study on lipid-induced insulin resistance in rat
skeletal muscle showed unaltered TBC1D4 phosphoryla-
tion at T642 (7), the predominant site on TBC1D4 recog-
nized by the PAS antibody (33). In line with these reports,
we observed intact phosphorylation of TBC1D4 T642 along
with intact phosphorylation of other Akt-regulated phos-
phorylation sites S318, S704, and S751 (Fig. 4B and E–G).
Although the ability for insulin to induce TBC1D4 S341
TABLE 2
RER, femoral venous blood ﬂow, arterial blood glucose concentration, plasma substrate and hormone concentration, lactate release,
and skeletal muscle glycogen and IMTG content
Saline Intralipid
Preclamp End of clamp Preclamp End of clamp
RER 0.79 6 0.02 0.85 6 0.02†† 0.78 6 0.02 0.77 6 0.02**
Blood ﬂow (mL $ min21)
Rested leg 365 6 3.7 473 6 4.2* 398 6 4.4 479 6 4.7*
Exercised leg 487 6 5.0 523 6 3.3* 442 6 3.9 539 6 3.6*
Arterial glucose (mmol $ L21) 5.3 6 0.1 5.2 6 0.1 5.3 6 0.1 5.2 6 0.1
Hepatic glucose production (µmol $ min21$ kg21) 15.5 6 0.6 21.8 6 1.8††† 15.5 6 0.5 6.6 6 3.7†††
Arterial plasma
LCFA (mmol $ L21) 488 6 124 27.7 6 7.50††† 2,370 6 377*** 1,894 6 300†††***
Insulin (mU $ mL21) 6.3 6 1.1 101 6 4.8††† 9.8 6 1.6 98 6 4.9†††
Epinephrine (nmol $ L21) 0.48 6 0.17 0.53 6 0.14 0.32 6 0.09 0.49 6 0.11
Norepinephrine (nmol $ L21) 0.88 6 0.22 1.03 6 0.22 0.81 6 0.24 0.87 6 0.25
Lactate release (mmol $ min21)
Rested leg 52.3 6 13.0 73.9 6 5.0 80.1 6 17.8** 90.1 6 6.8**
Exercised leg 31.8 6 9.7 52.1 6 9.1 65.0 6 10.1** 87.9 6 10.7**
Arterial lactate (mmol $ L21) 0.71 6 0.09 1.06 6 0.05†† 0.67 6 0.01 0.99 6 0.07††
Glycogen content (mmol $ kg21 dry weight)
Rested leg 511 6 21 511 6 22 478 6 37 518 6 44
Exercised leg 367 6 27# 381 6 24#† 324 6 23# 381 6 19#†
IMTG content (mmol $ kg21 dry weight)
Rested leg 37.3 6 4.1 34.7 6 4.7 32.1 6 5.2 45.7 6 5.0
Exercised leg 38.1 6 5.3 35.0 6 3.5 39.5 6 3.8 39.6 6 3.3
Data are expressed as means 6 SEM (n = 8). *P , 0.05, **P , 0.01, ***P , 0.001 vs. saline. †P , 0.05, ††P , 0.01, †††P , 0.001 vs. preclamp.
#P , 0.05 vs. rested leg.
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phosphorylation was normal (D values), the general level
of phosphorylation was impaired.
Previous reports have demonstrated that 14-3-3 binding
to TBC1D4 by itself was sufﬁcient to increase GLUT4
translocation (35) suggesting that 14-3-3 binding may
modify TBC1D4 GAP activity. Hence, because insulin-
induced 14-3-3 binding to TBC1D4 was not altered in the
intralipid trial, this could indicate that impaired S341
phosphorylation did not result in impaired GAP activity.
Knowledge of the regulation of TBC1D4 GAP activity by
phosphorylation and 14-3-3 binding and the contribution of
each individual phosphorylation site is still very limited,
and hence, whether 14-3-3 binding can be used as a sur-
rogate measure of GAP activity is not known. Nevertheless,
it seems well established that TBC1D4 phosphorylation is
involved in the regulation of insulin-stimulated GLUT4
translocation in adipocytes (32) and in insulin-stimulated
glucose uptake in mouse skeletal muscle (27). However, no
FIG. 2. Akt T308 phosphorylation (A), Akt S473 phosphorylation (B), and AMPK T172 phosphorylation/AMPK-a2 expression (C) in rested or
exercised (Ex’d) vastus lateralis muscle in the saline and lipid trials. D: Representative Western blots of Akt protein expression and site-speciﬁc
phosphorylation and AMPK-a2 protein expression and phosphorylation. Blots show the quality and signal obtained with the corresponding anti-
body and represent one subject; thus, they do not necessarily represent an exact mean of all subjects. Data are expressed as means 6 SEM (n = 8).
***P < 0.001 vs. basal (0 min.) in respective trial. AU, arbitrary units.
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conclusive data exist on the role TBC1D4 S341 in insulin-
stimulated glucose uptake because the studies examining
this matter (27,32) primarily have used a TBC1D4 4P mu-
tant in which four predicted Akt phosphorylation sites
(S318, S588, T642, and S751) have been mutated to ala-
nine. The TBC1D4 4P mutant does not include S341. In
fact, over-expressing a TBC1D4 S341 to an alanine mutant,
along with the 4P mutant in 3T3-L1 adipocytes, does not
exacerbate the effects of overexpressing the 4P mutant
(32). However, the TBC1D4 S341 mutant in that study was
only expressed simultaneously with the 4P mutant. Thus, it
cannot be ruled out that overexpressing mutated TBC1D4
S341 alone could negatively affect glucose uptake. None-
theless, given the involvement of TBC1D4 in insulin-
stimulated glucose uptake and that all measured TBC1D4
phosphorylation sites were potently phosphorylated by
insulin (Fig. 4B–G), it seems plausible to propose that
impaired TBC1D4 S341 phosphorylation could partially
inhibit the regulatory function of the protein. The positive
correlation between leg glucose uptake and TBC1D4 S341
phosphorylation during insulin stimulation in the current
study provides further support for this notion.
The beneﬁcial effect of prior exercise on insulin sensi-
tivity is characterized by an increased insulin-induced
abundance of GLUT4 at the plasma membrane (21) and by
increased activation of GS (22). In line with the latter, we
also observed increased GS activity in the previously ex-
ercised leg in the current study (Fig. 6A and B). Corre-
sponding with the similar GS activity in the saline versus
the lipid trial, we did not observe any differences in post-
exercise glycogen resynthesis between these two trials
(Table 2). This was despite the rather large relative differ-
ences in leg glucose uptake in the rested and exercised leg
between the two trials (Fig. 1). We note here that the numeric
differences in glucose uptake between the two trials are rel-
atively small compared with the levels of glycogen in the
muscle. Taking the accuracy of the glycogen measurements
into account, this could explain why we do not observe any
differences in glycogen resynthesis between the trials.
Recently, and as conﬁrmed by the current study, we
showed that the signaling nexus TBC1D4 could play a po-
tential role in the enhanced insulin action observed after
a single bout of exercise because the general level of
phosphorylation of all sites investigated was elevated by
prior exercise (26). In fact, a novel observation was the
very potent elevation of S704 phosphorylation. Although
phosphorylation was elevated on all sites in the previously
exercised leg, 14-3-3 binding to TBC1D4 did not follow this
FIG. 3. Site-speciﬁc phosphorylation in rested or exercised (Ex’d) vastus lateralis muscle in the saline and lipid trials. A: TBC1D1 pS237 phos-
phorylation/TBC1D1 protein expression. B: TBC1D1 pT596 phosphorylation/TBC1D1 protein expression. C: Representative Western blots of
TBC1D1 protein expression and phosphorylation show the quality and signal obtained with the corresponding antibody and represent one subject;
thus, they do not necessarily represent an exact mean of all subjects. Data are expressed as means 6 SEM (n = 8). **P < 0.01 vs. basal (0 min) in
respective trial. AU, arbitrary units.
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FIG. 4. 14-3-3 binding to TBC1D4 and site-speciﬁc phosphorylation in rested or exercised (Ex’d) vastus lateralis muscle in the saline and lipid
trials. A: 14-3-3 binding to TBC1D4/TBC1D4 protein expression. B: TBC1D4 S318 phosphorylation/TBC1D4 protein expression. C: TBC1D4 S341
phosphorylation/TBC1D4 protein expression. D: TBC1D4 S588 phosphorylation/TBC1D4 protein expression. E: TBC1D4 T642 phosphorylation/
TBC1D4 protein expression. F: TBC1D4 S704 phosphorylation/TBC1D4 protein expression. G: TBC1D4 S751 phosphorylation/TBC1D4 protein
expression. H: Representative Western blots of TBC1D4 phosphorylation and 14-3-3 binding to TBC1D4 show the quality and signal obtained with
the corresponding antibody and represent one subject; thus, they do not necessarily represent an exact mean of all subjects. Data are expressed as
means 6 SEM (n = 8). #P < 0.05 vs. saline trial; *P < 0.05, **P < 0.01, ***P < 0.001 vs. basal (0 min.) in respective trial; †P < 0.05, ††P < 0.01,
†††P < 0.001 vs. rested leg. AU, arbitrary units.
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pattern, conﬁrming our previous report (26). This under-
lines the imperative need for a better understanding of
TBC1D4 GAP activity regulation (Fig. 4A).
We anticipated that the closely related paralog TBC1D1
would show a similar pattern of regulation as TBC1D4 be-
cause these proteins share several similar structural fea-
tures. Both proteins contain two clusters of phosphorylation
sites, each containing a potential 14-3-3 binding site (Ser237
and Thr596 on TBC1D1 and Ser341 and Thr642 on TBC1D4)
(35,36), they show speciﬁcity toward the same Rabs (37),
and are potentially regulated by the same kinases. Although
it is well established that supraphysiologic insulin concen-
trations regulate TBC1D1 phosphorylation in cell systems
and in rodent skeletal muscle (37,38), we show, for the ﬁrst
time, that near-physiologic insulin concentrations regulate
TBC1D1 T596 phosphorylation in human skeletal muscle in
vivo. TBC1D1 S237 phosphorylation increases acutely dur-
ing exercise in human skeletal muscle (30,39). Although
a different exercise protocol was applied (the present pro-
tocol was relatively more intense), we anticipate a similar
acute phosphorylation of TBC1D1 during the exercise in
the current study. Interestingly, such phosphorylations were
normalized 5 h after exercise. Furthermore and in line with
the intact proximal insulin signaling, lipid infusion had no
effect on insulin-induced TBC1D1 phosphorylation.
Thus, our observations suggest that these two GTPase-
activating proteins are differentially regulated by prior ex-
ercise and lipid infusion. Under the conditions investigated,
TBC1D4 was affected by prior exercise and lipid infusion,
whereas TBC1D1 was not affected. The current study does
not bring evidence to clarify the basis for this difference.
TBC1D4 is a multikinase substrate phosphorylated by
various kinases. In cell-free assays, these include serum-
and glucocorticoid-induced protein kinase 1 (SGK1), p90
ribosomal S6 kinase 1 (RSK1), Akt, and AMPK (33), and
in Chinese hamster ovary cells, overexpressing insulin re-
ceptor, conventional/novel protein kinase C isoforms have
been proposed as upstream regulators of TBC1D4 (40). In
skeletal muscle, Akt and AMPK have been conﬁrmed as
upstream regulators of TBC1D4 phosphorylation (41,42).
AMPK is an important energy sensor in skeletal muscle
and can induce uptake of glucose when activated (43).
Moreover, decreased activity and/or protein expression of
AMPK has been observed in states of insulin resistance in
rodents (44). Although most studies in type 2 diabetic
patients do not observe impaired AMPK activity and/or
expression (45,46), the observations in rodents, along with
the impaired phosphorylation of TBC1D4 S341, which is
phosphorylated upon AMPK activation with AICAR in
human embryonic kidney 293 cells, led us to examine
FIG. 5. PDH site 1 and site 2 phosphorylation in rested or exercised (Ex’d) vastus lateralis muscle in the saline and lipid trials. A: PDH site
1 phosphorylation/PDH protein expression. B: PDH site 2 phosphorylation/PDH protein expression. C: Representative Western blots of PDH
protein expression and site-speciﬁc phosphorylation protein expression and phosphorylation show the quality and signal obtained with the cor-
responding antibody and represent one subject; thus, they do not necessarily represent an exact mean of all subjects. Data are expressed as
means 6 SEM (n = 8). (#)P = 0.08 vs. saline trial; †P < 0.05 vs. rested leg. AU, arbitrary units.
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AMPK phosphorylation in the current study (Fig. 2C).
Conﬁrming our previous report (11), AMPK T172 phos-
phorylation was completely unaffected by lipid infusion
(Fig. 2), and thus, the activity of other kinases and/or
phosphatases could be regulating TBC1D4 phosphoryla-
tion in vivo as well.
We show that intralipid infusion increased leg lactate
release, conﬁrming our recent ﬁnding (11) and leading us
to investigate the regulation of PDH. PDH phosphorylation
has been shown to inactivate the enzyme (47), and our
observations thus suggest that PDH activity was decreased
in the intralipid trial in line with the Randle cycle hy-
pothesis (12). In support of our observation, intralipid was
previously shown to inhibit the insulin-mediated decrease
in PDK4 mRNA in humans (8) and rats (7,48). However,
we recently reported unaltered PDH activity in human
skeletal muscle, despite lipid-induced increases in PDK4
mRNA expression and PDH-E1a phosphorylation (49).
Whether this discrepant ﬁnding relates to the sensitivity of
the activity assay is uncertain. However, the lower RER
values at the end of the clamp in the intralipid trial com-
pared with the saline trial in the current study, along with
higher leg lactate release in the intralipid trial, indicates
a lower degree of carbohydrate oxidation consistent with
lower conversion of pyruvate to acetyl-CoA. Whether this
reduced glucose oxidation could result in decreased glu-
cose uptake is still uncertain because we did not observe
any accumulation of glucose-6-phosphate or free glucose in
response to intralipid infusion in our recent study (11).
However, due to inherent difﬁculties in measuring these
variables, one cannot put too much weight on these nega-
tive results. We, therefore, cannot rule out that the Randle
cycle hypothesis is indeed applicable in this context.
In conclusion, the current study proposes two molecular
mechanisms—site-speciﬁc TBC1D4 and PDH phosphoryla-
tion—that both potentially account for part of the impairing
effect of intralipid on skeletal muscle glucose uptake. We
furthermore show that a previous bout of exercise partly
protects from subsequent lipid-induced insulin resistance in
humans at the level of skeletal muscle. This may potentially
occur through enhanced insulin action on speciﬁc TBC1D4
phosphorylation sites. Finally, we show that insulin in-
creased phosphorylation of the signaling nexus TBC1D1 in
humans independently of lipid infusion and prior exercise.
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